Substance Abuse

Adderall Addiction Treatment: Rebuilding Focus, Energy, and Stability

Begin Recovery

Misuse and dependency on prescription stimulants is more common than many people realize. Studies show approximately 5 to 35 percent of college students use prescription stimulants for non-medical reasons, and a significant portion of those develop a dependency. People with high-pressure jobs and those with undiagnosed ADHD are at even higher risk.

Yes. Adderall misuse is recognized as an addictive disorder and falls under the same continuum of care as any other substance use disorder. At Forward Motion Health, we provide a comprehensive, individualized residential program for people dealing with Adderall addiction.

Withdrawal symptoms typically begin within hours of the last dose and reach peak intensity within the first 3 to 5 days, then gradually resolve over 1 to 2 weeks. Some symptoms — low motivation, disrupted sleep, and mild depression — may continue intermittently as part of post-acute withdrawal, but these are significantly improved with a medically supervised taper and structured treatment program.

Yes. At higher doses, during chronic misuse, or when used alongside other substances, Adderall use can be associated with psychosis. Symptoms may include hallucinations, paranoia, and delusions. Although rare, Adderall-induced psychosis is a serious medical emergency that requires immediate intervention.

The brain’s dopamine and norepinephrine systems begin returning to normal once Adderall use stops, but full neurological recovery — including the return of natural motivation, energy, and mood stability — typically takes weeks to months. Ongoing structured therapy, support groups, and treatment of any underlying mental health conditions all support the recovery process.

Absolutely. In many cases, people who develop an Adderall addiction also have undiagnosed or undertreated ADHD that contributed to their use in the first place. Effective treatment addresses both the addiction and the underlying ADHD through non-stimulant medications, behavioral therapies, and sustainable executive functioning strategies.

[1] [3] U.S. Food and Drug Administration. (2023, October). Adderall (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate) tablets [Label]. accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf

[2] [8] StatPearls Publishing. (2025, April 6). Dextroamphetamine-amphetamine. National Library of Medicine. ncbi.nlm.nih.gov/books/NBK507808/


[4] [5] Volkow, N. D., et al. (2021). Chapter 2: How stimulants affect the brain and behavior. National Institute on Drug Abuse. ncbi.nlm.nih.gov/books/NBK576548/


[6] [7] Frontiers in Psychiatry. (2025, June 29). Misuse and diversion of stimulant medications prescribed for the treatment of ADHD: A systematic review. frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1612785/full

Call 24/7
Verify Insurance